T. Rowe Price Associates
HLTH

T. Rowe Price Associates’s Cue Health Inc. Common Stock HLTH Stock Holding History

T. Rowe Price Associates’s Portfolio HLTH Stock Details HLTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-21,612
Closed -$40K – 2974
2023
Q1 		$40K Buy
21,612
+3,109
+17% +$6.76K ﹤0.01% 2812
2022
Q4 		$38K Buy
18,503
+1,715
+10% +$5.42K ﹤0.01% 2841
2022
Q3 		$51K Buy
16,788
+6,505
+63% +$23.1K ﹤0.01% 2838
2022
Q2 		$33K Sell
10,283
-142,102
-93% -$770K ﹤0.01% 2905
2022
Q1 		$983K Buy
+152,385
New +$1.38M ﹤0.01% 2019

Other funds holding HLTH

KI
Koch Industries Wichita, Kansas $853M AUM 37.49% 1-Year Est. Return
OC
Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
JPC
Jabodon PT Co Reno, Nevada $1.02B AUM 22.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

T. Rowe Price Associates's HLTH Position: Q2 2023 in Review

T. Rowe Price Associates sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2023, closing a stake of 21,612 shares — an estimated $40K sold.

T. Rowe Price Associates first reported a position in HLTH in Q1 2022 and held it in 5 quarters. The position peaked at $983K in Q1 2022. 79 funds tracked by Wall St. Rank hold HLTH as of Q2 2023.

  • T. Rowe Price Associates reported no remaining Cue Health Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 21,612 Cue Health Inc. Common Stock shares in Q2 2023, an estimated $40K.
  • T. Rowe Price Associates first reported a position in Cue Health Inc. Common Stock in Q1 2022 and held it in 5 quarters.
  • T. Rowe Price Associates's Cue Health Inc. Common Stock position peaked at $983K in Q1 2022.
  • 79 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2023.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.